Stock Report

All about this stock under one free report Last Updated: 15-May-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

CalAmp Corp. (CAMP)

Stock Card factsheet share-fund-plan-icon

$4.41

up-down-arrow $0.03 (0.68%)

As on 15-May-2026 10:39EDT

Market cap

info icon

$228 Mln

Revenue (TTM)

info icon

$3 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

7.5

Div. Yield

info icon

0 %

CalAmp (CAMP) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 4.26 High: 4.45

52 Week Range

Low: 1.31 High: 7.75

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -2.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    43.59

  • EV/EBITDAEV/EBITDA information

    0

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    51,925,800

10 Years Aggregate

CFO

$229.45 Mln

EBITDA

$208.12 Mln

Net Profit

$-195.52 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
CalAmp (CAMP)
-28.1 -2.4 14.5 137.1 -51.6 -56.8 -35.1
BSE Sensex
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 15-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
CalAmp (CAMP)
17.4 -9.1 -94.4 -36.5 -28.8 3.5 -26.4
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
CalAmp (CAMP)
4.4 228.5 2.6 -86.3 -1,549.4 -192.7 -- 7.5
AT&T (T)
24.7 172,805.2 126,528.0 21,367.0 26.0 18.4 8.2 1.6
Globalstar (GSAT)
81.8 10,592.9 283.0 -14.0 -6.8 -4 -- 30.8
Gogo (GOGO)
4.0 569.4 906.5 14.0 11.0 12.4 42.1 5.0
Iridium Communications (IRDM)
42.3 4,562.2 875.8 105.6 26.2 23 43.6 9.4
Shenandoah Telecommunications Co (SHEN)
16.2 885.2 362.1 -44.6 -5.3 -5.1 -- 1.0
Spok Holdings (SPOK)
10.9 222.7 136.6 12.7 12.4 8.7 18.1 1.6
Telephone and Data Systems (TDS)
41.6 4,930.8 2,134.7 114.0 11.5 1.9 25.5 1.4
TIM Participacoes SA (TIMB)
22.1 11,140.8 27,151.2 4,845.6 28.8 19.7 12.9 2.3
T-Mobile US (TMUS)
188.9 206,538.8 90,530.0 10,543.0 18.4 18.1 20.3 3.8

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About CalAmp (CAMP)

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the...  treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: One Kendall Square, Cambridge, MA, United States, 02139  Read more

  • Senior VP & CFO

    Mr. Jikun Kim

  • Senior VP & CFO

    Mr. Jikun Kim

  • Headquarters

    Cambridge, MA

  • Website

    https://www.camp4tx.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for CalAmp (CAMP)

The share price of CalAmp Corp (CAMP) is $4.41 (NASDAQ) as of 15-May-2026 10:39 EDT. CalAmp Corp (CAMP) has given a return of -51.59% in the last 3 years.

Since, TTM earnings of CalAmp Corp (CAMP) is negative, P/E ratio is not available.
The P/B ratio of CalAmp Corp (CAMP) is 7.49 times as on 12-May-2026, a 100 premium to its peers’ median range of 3.75 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-2.29
3.86
2024
-0.50
0.41
2024
--
--
2023
--
--
2023
--
--

The 52-week high and low of CalAmp Corp (CAMP) are Rs 7.75 and Rs 1.31 as of 15-May-2026.

CalAmp Corp (CAMP) has a market capitalisation of $ 228 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in CalAmp Corp (CAMP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.